Tang W, Zheng K, Sun S, Zhong B, Luo Z, Yang J
Int J Mol Sci. 2024; 25(23).
PMID: 39684588
PMC: 11641339.
DOI: 10.3390/ijms252312879.
Fernandez-Quintero M, Guarnera E, Musil D, Pekar L, Sellmann C, Freire F
Protein Sci. 2024; 33(11):e5176.
PMID: 39422475
PMC: 11487682.
DOI: 10.1002/pro.5176.
Yu T, Zheng F, He W, Muyldermans S, Wen Y
Immunol Rev. 2024; 328(1):98-112.
PMID: 39166870
PMC: 11659936.
DOI: 10.1111/imr.13381.
Zettl I, Bauernfeind C, Kollarova J, Flicker S
Int J Mol Sci. 2024; 25(14).
PMID: 39062843
PMC: 11277559.
DOI: 10.3390/ijms25147602.
Conca W, Saleh S, Al-Rabiah R, Parhar R, Abd-Elnaeim M, Al-Hindas H
Front Immunol. 2024; 14:1289769.
PMID: 38162642
PMC: 10756906.
DOI: 10.3389/fimmu.2023.1289769.
A library approach for the high-throughput isolation of humanized VHH domains with favorable developability properties following camelid immunization.
Arras P, Yoo H, Pekar L, Schroter C, Clarke T, Krah S
MAbs. 2023; 15(1):2261149.
PMID: 37766540
PMC: 10540653.
DOI: 10.1080/19420862.2023.2261149.
NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
Jin B, Odongo S, Radwanska M, Magez S
Int J Mol Sci. 2023; 24(6).
PMID: 36983063
PMC: 10057852.
DOI: 10.3390/ijms24065994.
Application Progress of the Single Domain Antibody in Medicine.
Tang H, Gao Y, Han J
Int J Mol Sci. 2023; 24(4).
PMID: 36835588
PMC: 9967291.
DOI: 10.3390/ijms24044176.
Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging.
Mulero F, Oteo M, Garaulet G, Magro N, Rebollo L, Medrano G
Front Med (Lausanne). 2022; 9:1058455.
PMID: 36507540
PMC: 9729729.
DOI: 10.3389/fmed.2022.1058455.
Characterization of rabbit polyclonal antibody against camel recombinant nanobodies.
Khalaf H, Al-Bouqaee H, Hwijeh M, Abbady A
Open Life Sci. 2022; 17(1):659-675.
PMID: 35800073
PMC: 9202535.
DOI: 10.1515/biol-2022-0065.
Neutralizing Dromedary-Derived Nanobodies Against BotI-Like Toxin From the Most Hazardous Scorpion Venom in the Middle East and North Africa Region.
Ben Abderrazek R, Ksouri A, Idoudi F, Dhaouadi S, Hamdi E, Vincke C
Front Immunol. 2022; 13:863012.
PMID: 35514999
PMC: 9063451.
DOI: 10.3389/fimmu.2022.863012.
Prospects of Neutralizing Nanobodies Against SARS-CoV-2.
Chen F, Liu Z, Jiang F
Front Immunol. 2021; 12:690742.
PMID: 34122456
PMC: 8194341.
DOI: 10.3389/fimmu.2021.690742.
Application of Single-Domain Antibodies ("Nanobodies") to Laboratory Diagnosis.
Pillay T, Muyldermans S
Ann Lab Med. 2021; 41(6):549-558.
PMID: 34108282
PMC: 8203438.
DOI: 10.3343/alm.2021.41.6.549.
Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19).
Bessalah S, Jebahi S, Mejri N, Salhi I, Khorchani T, Hammadi M
3 Biotech. 2021; 11(2):89.
PMID: 33500874
PMC: 7820838.
DOI: 10.1007/s13205-021-02647-5.
A guide to: generation and design of nanobodies.
Muyldermans S
FEBS J. 2020; 288(7):2084-2102.
PMID: 32780549
PMC: 8048825.
DOI: 10.1111/febs.15515.
VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis.
Low S, Wu H, Jerath K, Tibolla A, Fogal B, Conrad R
MAbs. 2020; 12(1):1709322.
PMID: 31924119
PMC: 6973309.
DOI: 10.1080/19420862.2019.1709322.
The Camel Adaptive Immune Receptors Repertoire as a Singular Example of Structural and Functional Genomics.
Ciccarese S, Burger P, Ciani E, Castelli V, Linguiti G, Plasil M
Front Genet. 2019; 10:997.
PMID: 31681428
PMC: 6812646.
DOI: 10.3389/fgene.2019.00997.
An improved yeast surface display platform for the screening of nanobody immune libraries.
Uchanski T, Zogg T, Yin J, Yuan D, Wohlkonig A, Fischer B
Sci Rep. 2019; 9(1):382.
PMID: 30674983
PMC: 6344588.
DOI: 10.1038/s41598-018-37212-3.
Use of camel single-domain antibodies for the diagnosis and treatment of zoonotic diseases.
Lafaye P, Li T
Comp Immunol Microbiol Infect Dis. 2018; 60:17-22.
PMID: 30396425
PMC: 7112682.
DOI: 10.1016/j.cimid.2018.09.009.
Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in Mice.
Zhang T, Cheng X, Yu D, Lin F, Hou N, Cheng X
Front Immunol. 2018; 9:2202.
PMID: 30319646
PMC: 6167435.
DOI: 10.3389/fimmu.2018.02202.
